{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T19:31:43Z","timestamp":1780083103163,"version":"3.54.0"},"reference-count":153,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,7,20]],"date-time":"2023-07-20T00:00:00Z","timestamp":1689811200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>The relationship between metabolic and inflammatory pathways play a pathogenic role in various cardiometabolic disorders and is potentially also involved in the pathogenesis of other disorders such as cancer, autoimmunity and infectious diseases. Common variable immunodeficiency (CVID) is the most common primary immunodeficiency in adults, characterized by increased frequency of airway infections with capsulated bacteria. In addition, a large proportion of CVID patients have autoimmune and inflammatory complications associated with systemic inflammation. We summarize the evidence that support a role of a bidirectional pathogenic interaction between inflammation and metabolic disturbances in CVID. This include low levels and function of high-density lipoprotein (HDL), high levels of triglycerides (TG) and its major lipoprotein very low-density lipoprotein (VLDL), and an unfavorable fatty acid (FA) profile. The dysregulation of TG, VLDL and FA were linked to disturbed gut microbiota profile, and TG and VLDL levels were strongly associated with lipopolysaccharides (LPS), a marker of gut leakage in blood. Of note, the disturbed lipid profile in CVID did not include total cholesterol levels or high low-density lipoprotein levels. Furthermore, increased VLDL and TG levels in blood were not associated with diet, high body mass index and liver steatosis, suggesting a different phenotype than in patients with traditional cardiovascular risk such as metabolic syndrome. We hypothesize that these metabolic disturbances are linked to inflammation in a bidirectional manner with disturbed gut microbiota as a potential contributing factor.<\/jats:p>","DOI":"10.3389\/fimmu.2023.1199727","type":"journal-article","created":{"date-parts":[[2023,7,20]],"date-time":"2023-07-20T17:11:05Z","timestamp":1689873065000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":17,"title":["Disturbed lipid profile in common variable immunodeficiency \u2013 a pathogenic loop of inflammation and metabolic disturbances"],"prefix":"10.3389","volume":"14","author":[{"given":"Silje F.","family":"Jorgensen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magnhild E.","family":"Macpherson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tonje","family":"Skarpengland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rolf K.","family":"Berge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B\u00f8rre","family":"Fevang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bente","family":"Halvorsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P\u00e5l","family":"Aukrust","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,7,20]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2013.02.028","article-title":"Interactions between inflammation and lipid metabolism: relevance for efficacy of anti-inflammatory drugs in the treatment of atherosclerosis","volume":"228","author":"van Diepen","year":"2013","journal-title":"Atherosclerosis"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.119.315896","article-title":"Metabolic inflammation and insulin resistance in obesity","volume":"126","author":"Wu","year":"2020","journal-title":"Circ Res"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/S0939-4753(04)80048-6","article-title":"The metabolic syndrome and inflammation: association or causation","volume":"14","author":"Esposito","year":"2004","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1007\/s12272-016-0827-4","article-title":"Mitochondria and the NLRP3 inflammasome: physiological and pathological relevance","volume":"39","author":"Yu","year":"2016","journal-title":"Arch Pharm Res"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.20900\/immunometab20200012","article-title":"Metabolic targets for treatment of autoimmune diseases","volume":"2","author":"Piranavan","year":"2020","journal-title":"Immunometabolism"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.it.2018.04.006","article-title":"Metabolism as a target for modulation in autoimmune diseases","volume":"39","author":"Huang","year":"2018","journal-title":"Trends Immunol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.00141","article-title":"A role for the Krebs cycle intermediate citrate in metabolic reprogramming in innate immunity and inflammation","volume":"9","author":"Williams","year":"2018","journal-title":"Front Immunol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.molcel.2020.04.002","article-title":"Cytokine-like roles for metabolites in immunity","volume":"78","author":"Zas\u0142ona","year":"2020","journal-title":"Mol Cell"},{"key":"B9","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1182\/blood-2010-01-254417","article-title":"How I treat common variable immune deficiency","volume":"116","author":"Cunningham-Rundles","year":"2010","journal-title":"Blood"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1086\/587669","article-title":"Infections in 252 patients with common variable immunodeficiency","volume":"46","author":"Oksenhendler","year":"2008","journal-title":"Clin Infect Dis"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-11-124545","article-title":"Common variable immunodeficiency disorders: division into distinct clinical phenotypes","volume":"112","author":"Chapel","year":"2008","journal-title":"Blood"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.857050","article-title":"Seeking relevant biomarkers in common variable immunodeficiency","volume":"13","author":"Ho","year":"2022","journal-title":"Front Immunol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1146\/annurev-pathmechdis-031521-024229","article-title":"Common variable immunodeficiency: more pathways than roads to Rome","volume":"18","author":"Peng","year":"2023","journal-title":"Annu Rev Pathol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-014-0053-0","article-title":"Cytokines in common variable immunodeficiency as signs of immune dysregulation and potential therapeutic targets - a review of the current knowledge","volume":"34","author":"Varzaneh","year":"2014","journal-title":"J Clin Immunol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1080\/1744666X.2021.2008241","article-title":"Gut inflammation in CVID: causes and consequences","volume":"18","author":"Andersen","year":"2022","journal-title":"Expert Rev Clin Immunol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-018-0574-z","article-title":"Autoimmunity and inflammation in CVID: a possible crosstalk between immune activation, gut microbiota, and epigenetic modifications","volume":"39","author":"Jorgensen","year":"2019","journal-title":"J Clin Immunol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.712915","article-title":"Gut microbiome and common variable immunodeficiency: few certainties and many outstanding questions","volume":"12","author":"Varricchi","year":"2021","journal-title":"Front Immunol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3390\/nu2020116","article-title":"Dietary phospholipids and intestinal cholesterol absorption","volume":"2","author":"Cohn","year":"2010","journal-title":"Nutrients"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1038\/s41580-019-0190-7","article-title":"Mechanisms and regulation of cholesterol homeostasis","volume":"21","author":"Luo","year":"2020","journal-title":"Nat Rev Mol Cell Biol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"760","DOI":"10.3390\/nu10060760","article-title":"Molecular pathways underlying cholesterol homeostasis","volume":"10","author":"Afonso","year":"2018","journal-title":"Nutrients"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbalip.2009.01.002","article-title":"Niemann\u2013pick C1 like 1 (NPC1L1) an intestinal sterol transporter","volume":"1791","author":"Davis","year":"2009","journal-title":"Biochim Biophys Acta (BBA)-Molecular Cell Biol Lipids"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1038\/s41575-019-0250-7","article-title":"Regulation of intestinal lipid metabolism: current concepts and relevance to disease","volume":"17","author":"Ko","year":"2020","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"782","DOI":"10.3390\/biomedicines9070782","article-title":"The importance of lipoprotein lipase regulation in atherosclerosis","volume":"9","author":"Kumari","year":"2021","journal-title":"Biomedicines"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1126\/science.abe6729","article-title":"Enterically derived high-density lipoprotein restrains liver injury through the portal vein","volume":"373","author":"Han","year":"2021","journal-title":"Science"},{"key":"B25","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/S0002-9149(00)01461-2","article-title":"The metabolic pathways of high-density lipoprotein, low-density lipoprotein, and triglycerides: a current review","volume":"86","author":"Kwiterovich","year":"2000","journal-title":"Am J Cardiol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1038\/ncb0903-769","article-title":"Unfolding the toxicity of cholesterol","volume":"5","author":"Zhang","year":"2003","journal-title":"Nat Cell Biol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.613780","article-title":"Overview of OxLDL and its impact on cardiovascular health: focus on atherosclerosis","volume":"2248","author":"Poznyak","year":"2021","journal-title":"Front Pharmacol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.119.312617","article-title":"HDL and reverse cholesterol transport: basic mechanisms and their roles in vascular health and disease","volume":"124","author":"Ouimet","year":"2019","journal-title":"Circ Res"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1038\/mi.2016.18","article-title":"Altered gut microbiota profile in common variable immunodeficiency associates with levels of lipopolysaccharide and markers of systemic immune activation","volume":"9","author":"Jorgensen","year":"2016","journal-title":"Mucosal Immunol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2018.00526","article-title":"Reverse cholesterol transport: molecular mechanisms and the non-medical approach to enhance HDL cholesterol","volume":"9","author":"Marques","year":"2018","journal-title":"Front Physiol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.119.312617","article-title":"HDL and reverse cholesterol transport","volume":"124","author":"Ouimet","year":"2019","journal-title":"Circ Res"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.111.258673","article-title":"Novel biological functions of high-density lipoprotein cholesterol","volume":"111","author":"Mineo","year":"2012","journal-title":"Circ Res"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1089\/jir.2019.0029","article-title":"High-density lipoproteins decrease proinflammatory activity and modulate the innate immune response","volume":"39","author":"Taborda","year":"2019","journal-title":"J Interferon Cytokine Res"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.RA118.002428","article-title":"High-density lipoprotein inhibits serum amyloid a-mediated reactive oxygen species generation and NLRP3 inflammasome activation","volume":"293","author":"Shridas","year":"2018","journal-title":"J Biol Chem"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1111\/imm.12638","article-title":"High-density lipoprotein reduces inflammation from cholesterol crystals by inhibiting inflammasome activation","volume":"149","author":"Thacker","year":"2016","journal-title":"Immunology"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1403044","article-title":"Reconstituted high-density lipoprotein attenuates cholesterol crystal-induced inflammatory responses by reducing complement activation","volume":"195","author":"Niyonzima","year":"2015","journal-title":"J Immunol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.119.313253","article-title":"Anti-inflammatory effects of HDL (High-density lipoprotein) in macrophages predominate over proinflammatory effects in atherosclerotic plaques","volume":"39","author":"Fotakis","year":"2019","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1159\/000435818","article-title":"Higher cardiovascular risk in common variable immunodeficiency and X-linked agammaglobulinaemia patients","volume":"66","author":"Vieira","year":"2015","journal-title":"Ann Nutr Metab"},{"key":"B39","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s12865-021-00425-9","article-title":"Selenium-related nutritional status in patients with common variable immunodeficiency: association with oxidative stress and atherosclerosis risk","volume":"22","author":"Andrade","year":"2021","journal-title":"BMC Immunol"},{"key":"B40","doi-asserted-by":"publisher","first-page":"9427","DOI":"10.1038\/s41598-019-45861-1","article-title":"Impaired HDL function amplifies systemic inflammation in common variable immunodeficiency","volume":"9","author":"Macpherson","year":"2019","journal-title":"Sci Rep"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.115.306052","article-title":"Small HDL promotes cholesterol efflux by the ABCA1 pathway in macrophages: implications for therapies targeted to HDL","author":"Heinecke","year":"2015","journal-title":"Am Heart Assoc"},{"key":"B42","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.biomaterials.2016.05.021","article-title":"Synthetic high-density lipoprotein-like nanoparticles potently inhibit cell signaling and production of inflammatory mediators induced by lipopolysaccharide binding toll-like receptor 4","volume":"100","author":"Foit","year":"2016","journal-title":"Biomaterials"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1038\/ni.2784","article-title":"High-density lipoprotein mediates anti-inflammatory reprogramming of macrophages via the transcriptional regulator ATF3","volume":"15","author":"De Nardo","year":"2014","journal-title":"Nat Immunol"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.114.303553","article-title":"Anti-inflammatory effects of high-density lipoprotein through activating transcription factor 3: benefit beyond cholesterol transport-dependent processes","volume":"34","author":"Zhang","year":"2014","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2020.00556","article-title":"Master regulator activating transcription factor 3 (ATF3) in metabolic homeostasis and cancer","volume":"11","author":"Ku","year":"2020","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M109.047472","article-title":"The macrophage cholesterol exporter ABCA1 functions as an anti-inflammatory receptor","volume":"284","author":"Tang","year":"2009","journal-title":"J Biol Chem"},{"key":"B47","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.cmet.2016.10.013","article-title":"High-density lipoproteins exert pro-inflammatory effects on macrophages via passive cholesterol depletion and PKC-NF-\u03baB\/STAT1-IRF1 signaling","volume":"25","author":"van der Vorst","year":"2017","journal-title":"Cell Metab"},{"key":"B48","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.cmet.2017.04.007","article-title":"Pro- versus anti-inflammatory actions of HDLs in innate immunity","volume":"26","author":"Kopecky","year":"2017","journal-title":"Cell Metab"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2021.12.009","article-title":"High-density lipoproteins and immune response: a review","volume":"195","author":"Grao-Cruces","year":"2022","journal-title":"Int J Biol Macromol"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2012.07.029","article-title":"HDL and ApoA-I inhibit antigen presentation-mediated T cell activation by disrupting lipid rafts in antigen presenting cells","volume":"225","author":"Wang","year":"2012","journal-title":"Atherosclerosis"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M110.134130","article-title":"Apolipoprotein a-I modulates regulatory T cells in autoimmune LDLr-\/-, ApoA-i-\/- mice","volume":"285","author":"Wilhelm","year":"2010","journal-title":"J Biol Chem"},{"key":"B52","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1007\/3-540-27702-1_7","article-title":"Dendritic cells: key cells for the induction of regulatory T cells","volume":"293","author":"Mahnke","year":"2005","journal-title":"Curr Top Microbiol Immunol"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.633436","article-title":"Regulatory dendritic cells, T cell tolerance, and dendritic cell therapy for immunologic disease","volume":"12","author":"Ness","year":"2021","journal-title":"Front Immunol"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1038\/nri1485","article-title":"Regulatory T cells: friend or foe in immunity to infection","volume":"4","author":"Mills","year":"2004","journal-title":"Nat Rev Immunol"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2249.2006.03314.x","article-title":"Low numbers of regulatory T cells in common variable immunodeficiency: association with chronic inflammation in vivo","volume":"147","author":"Fevang","year":"2007","journal-title":"Clin Exp Immunol"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1194\/jlr.M072835","article-title":"High density lipoproteins selectively promote the survival of human regulatory T cells","volume":"58","author":"Rueda","year":"2017","journal-title":"J Lipid Res"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1194\/jlr.C078618","article-title":"Anti-inflammatory liaisons: T regulatory cells and HDL","volume":"58","author":"Sorci-Thomas","year":"2017","journal-title":"J Lipid Res"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1093\/cvr\/cvu150","article-title":"HDL in innate and adaptive immunity","volume":"103","author":"Catapano","year":"2014","journal-title":"Cardiovasc Res"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.2174\/0929867325666180530094819","article-title":"Triglyceride-rich lipoproteins as a source of proinflammatory lipids in the arterial wall","volume":"26","author":"\u00d6\u00f6rni","year":"2019","journal-title":"Curr Med Chem"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1194\/jlr.M700505-JLR200","article-title":"Triglyceride-rich lipoprotein lipolysis releases neutral and oxidized FFAs that induce endothelial cell inflammation","volume":"50","author":"Wang","year":"2009","journal-title":"J Lipid Res"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23084300","article-title":"Emerging evidence of pathological roles of very-Low-Density lipoprotein (VLDL)","volume":"23","author":"Huang","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B62","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10875-023-01475-x","article-title":"Increased plasma levels of triglyceride-enriched lipoproteins associate with systemic inflammation, lipopolysaccharides, and gut dysbiosis in common variable immunodeficiency","author":"Macpherson","year":"2023","journal-title":"J Clin Immunol"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1194\/jlr.R300019-JLR200","article-title":"Effects of infection and inflammation on lipid and lipoprotein metabolism: mechanisms and consequences to the host","volume":"45","author":"Khovidhunkit","year":"2004","journal-title":"J Lipid Res"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1086\/315611","article-title":"Infection and inflammation-induced proatherogenic changes of lipoproteins","author":"Khovidhunkit","year":"2000","journal-title":"J Infect Dis"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(18)47576-X","article-title":"Multiple effects of tumor necrosis factor on lipoprotein lipase in vivo","volume":"262","author":"Semb","year":"1987","journal-title":"J Biol Chem"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M412189200","article-title":"Differential effects of lipoprotein lipase on tumor necrosis factor-alpha and interferon-gamma-mediated gene expression in human endothelial cells","volume":"280","author":"Kota","year":"2005","journal-title":"J Biol Chem"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1172\/JCI86610","article-title":"ApoC-III inhibits clearance of triglyceride-rich lipoproteins through LDL family receptors","volume":"126","author":"Gordts","year":"2016","journal-title":"J Clin Invest"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1097\/MED.0000000000000136","article-title":"Apolipoprotein c-III: a potent modulator of hypertriglyceridemia and cardiovascular disease","volume":"22","author":"Kohan","year":"2015","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2022.909151","article-title":"Triglyceride and triglyceride-rich lipoproteins in atherosclerosis","volume":"9","author":"Zhang","year":"2022","journal-title":"Front Mol Biosci"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2005.07.123","article-title":"Very low-density lipoprotein induces interleukin-1beta expression in macrophages","volume":"335","author":"Stollenwerk","year":"2005","journal-title":"Biochem Biophys Res Commun"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2011.09.046","article-title":"Eicosapentaenoic acid administration attenuates the pro-inflammatory properties of VLDL by decreasing its susceptibility to lipoprotein lipase in macrophages","volume":"219","author":"Jinno","year":"2011","journal-title":"Atherosclerosis"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2004.12.002","article-title":"Very low density lipoprotein potentiates tumor necrosis factor-alpha expression in macrophages","volume":"179","author":"Stollenwerk","year":"2005","journal-title":"Atherosclerosis"},{"key":"B73","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1038\/s41590-019-0548-1","article-title":"Apolipoprotein C3 induces inflammation and organ damage by alternative inflammasome activation","volume":"21","author":"Zewinger","year":"2020","journal-title":"Nat Immunol"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-023-01423-2","article-title":"Apolipoprotein C3 induces inflammasome activation only in its delipidated form","volume":"24","author":"Hsu","year":"2023","journal-title":"Nat Immunol"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-023-01424-1","article-title":"Reply to: apolipoprotein C3 induces inflammasome activation only in its delipidated form","volume":"24","author":"Zewinger","year":"2023","journal-title":"Nat Immunol"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2016.06.193","article-title":"Elevated levels of triglycerides and vldl-cholesterol provoke activation of nlrp1 inflammasome in endothelial cells","volume":"220","author":"Bleda","year":"2016","journal-title":"Int J Cardiol"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1055\/s-0039-1695008","article-title":"Fibrin-VLDL receptor-dependent pathway promotes leukocyte transmigration by inhibiting src kinase fyn and is a target for fibrin \u03b215-42 peptide","volume":"119","author":"Yakovlev","year":"2019","journal-title":"Thromb Haemost"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2249.1994.tb06073.x","article-title":"Enhanced generation of reactive oxygen species in monocytes from patients with common variable immunodeficiency","volume":"97","author":"Aukrust","year":"1994","journal-title":"Clin Exp Immunol"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V87.2.674.bloodjournal872674","article-title":"Persistent activation of the tumor necrosis factor system in a subgroup of patients with common variable immunodeficiency\u2013possible immunologic and clinical consequences","volume":"87","author":"Aukrust","year":"1996","journal-title":"Blood"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1182\/asheducation.V2012.1.301.3798316","article-title":"The many faces of common variable immunodeficiency","volume":"2012","author":"Cunningham-Rundles","year":"2012","journal-title":"Hematol Am Soc Hematol Educ Program"},{"key":"B81","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1016\/j.autrev.2012.11.003","article-title":"Common variable immunodeficiency: crossroads between infections, inflammation and autoimmunity","volume":"12","author":"Baldovino","year":"2013","journal-title":"Autoimmun Rev"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.3390\/ijms16023831","article-title":"Fatty acid signaling: the new function of intracellular lipases","volume":"16","author":"Papackova","year":"2015","journal-title":"Int J Mol Sci"},{"key":"B83","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.3390\/nu10101561","article-title":"Polyunsaturated fatty acids and their potential therapeutic role in cardiovascular system disorders-a review","volume":"10","author":"Soko\u0142a-Wysocza\u0144ska","year":"2018","journal-title":"Nutrients"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.997403","article-title":"Eicosanoids in inflammation in the blood and the vessel","volume":"3973","author":"Yamaguchi","year":"2022","journal-title":"Front Pharmacol"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20205028","article-title":"Effects of omega-3 fatty acids on immune cells","volume":"20","author":"Guti\u00e9rrez","year":"2019","journal-title":"Int J Mol Sci"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1097\/MCO.0000000000000865","article-title":"Polyunsaturated fatty acids and metabolic health: novel insights","volume":"25","author":"Djuricic","year":"2022","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2011.02.014","article-title":"PPARs are a unique set of fatty acid regulated transcription factors controlling both lipid metabolism and inflammation","volume":"1812","author":"Varga","year":"2011","journal-title":"Biochim Biophys Acta"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1097\/MOL.0b013e32832fa5c4","article-title":"Toll-like receptor signaling links dietary fatty acids to the metabolic syndrome","volume":"20","author":"Fessler","year":"2009","journal-title":"Curr Opin Lipidol"},{"key":"B89","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1146\/annurev-nutr-071816-064836","article-title":"Fatty acids and NLRP3 inflammasome-mediated inflammation in metabolic tissues","volume":"37","author":"Ralston","year":"2017","journal-title":"Annu Rev Nutr"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1152\/ajpendo.00436.2007","article-title":"Fatty acid-induced NF-kappaB activation and insulin resistance in skeletal muscle are chain length dependent","volume":"296","author":"Hommelberg","year":"2009","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1172\/JCI57132","article-title":"Inflammatory links between obesity and metabolic disease","volume":"121","author":"Lumeng","year":"2011","journal-title":"J Clin Invest"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbalip.2016.11.003","article-title":"Palmitate promotes inflammatory responses and cellular senescence in cardiac fibroblasts","volume":"1862","author":"Sokolova","year":"2017","journal-title":"Biochim Biophys Acta Mol Cell Biol Lipids"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-021-01146-9","article-title":"Altered plasma fatty acids associate with gut microbial composition in common variable immunodeficiency","volume":"42","author":"Skarpengland","year":"2022","journal-title":"J Clin Immunol"},{"key":"B94","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1146\/annurev-pharmtox-051921-090208","article-title":"Pros and cons of long-chain omega-3 polyunsaturated fatty acids in cardiovascular health","volume":"63","author":"Djuricic","year":"2023","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"B95","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11883-022-01075-x","article-title":"Role of omega-3 fatty acids in cardiovascular disease: the debate continues","volume":"25","author":"Sherratt","year":"2023","journal-title":"Curr Atheroscler Rep"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1093\/ajcn\/nqz349","article-title":"Dietary intake and biomarkers of linoleic acid and mortality: systematic review and meta-analysis of prospective cohort studies","volume":"112","author":"Li","year":"2020","journal-title":"Am J Clin Nutr"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(17)30307-8","article-title":"Omega-6 fatty acid biomarkers and incident type 2 diabetes: pooled analysis of individual-level data for 39\u2008740 adults from 20 prospective cohort studies","volume":"5","author":"Wu","year":"2017","journal-title":"Lancet Diabetes Endocrinol"},{"key":"B98","doi-asserted-by":"publisher","first-page":"2421","DOI":"10.3390\/nu13072421","article-title":"Beneficial outcomes of omega-6 and omega-3 polyunsaturated fatty acids on human health: an update for 2021","volume":"13","author":"Djuricic","year":"2021","journal-title":"Nutrients"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2017-212274","article-title":"High erythrocyte levels of the n-6 polyunsaturated fatty acid linoleic acid are associated with lower risk of subsequent rheumatoid arthritis in a southern European nested case-control study","volume":"77","author":"de Pablo","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2015.03.100","article-title":"N-3 polyunsaturated fatty acids modulate b cell activity in pre-clinical models: implications for the immune response to infections","volume":"785","author":"Whelan","year":"2016","journal-title":"Eur J Pharmacol"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.1016\/j.plefa.2018.03.004","article-title":"Omega-6 fatty acids and inflammation","volume":"132","author":"Innes","year":"2018","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"B102","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1038\/s41392-020-00443-w","article-title":"Metabolism pathways of arachidonic acids: mechanisms and potential therapeutic targets","volume":"6","author":"Wang","year":"2021","journal-title":"Signal transduction targeted Ther"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.170.11.5772","article-title":"Impaired secretion of IL-10 by T cells from patients with common variable immunodeficiency\u2013involvement of protein kinase a type I","volume":"170","author":"Holm","year":"2003","journal-title":"J Immunol"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.162.2.1178","article-title":"Increased activation of protein kinase a type I contributes to the T cell deficiency in common variable immunodeficiency","volume":"162","author":"Aukrust","year":"1999","journal-title":"J Immunol"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1801653","article-title":"Anti-inflammatory and proresolving effects of the omega-6 polyunsaturated fatty acid adrenic acid","volume":"205","author":"Brouwers","year":"2020","journal-title":"J Immunol"},{"key":"B106","doi-asserted-by":"publisher","first-page":"158936","DOI":"10.1016\/j.bbalip.2021.158936","article-title":"Polyunsaturated fatty acids, specialized pro-resolving mediators, and targeting inflammation resolution in the age of precision nutrition","volume":"1866","author":"Al-Shaer","year":"2021","journal-title":"Biochim Biophys Acta Mol Cell Biol Lipids"},{"key":"B107","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1038\/s41422-020-0332-7","article-title":"Interaction between microbiota and immunity in health and disease","volume":"30","author":"Zheng","year":"2020","journal-title":"Cell Res"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2014.03.011","article-title":"Role of the microbiota in immunity and inflammation","volume":"157","author":"Belkaid","year":"2014","journal-title":"Cell"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.00282","article-title":"Crosstalk between gut microbiota and innate immunity and its implication in autoimmune diseases","volume":"11","author":"Jiao","year":"2020","journal-title":"Front Immunol"},{"key":"B110","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1038\/nature18846","article-title":"Diet-microbiota interactions as moderators of human metabolism","volume":"535","author":"Sonnenburg","year":"2016","journal-title":"Nature"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.01921","article-title":"Commentary: gut antibody deficiency in a mouse model of CVID results in spontaneous development of a gluten-sensitive enteropathy","volume":"11","author":"Jorgensen","year":"2020","journal-title":"Front Immunol"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.1038\/nm.2505","article-title":"Crosstalk between b lymphocytes, microbiota and the intestinal epithelium governs immunity versus metabolism in the gut","volume":"17","author":"Shulzhenko","year":"2011","journal-title":"Nat Med"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2018.09.008","article-title":"CVID enteropathy is characterized by exceeding low mucosal IgA levels and interferon-driven inflammation possibly related to the presence of a pathobiont","volume":"197","author":"Shulzhenko","year":"2018","journal-title":"Clin Immunol"},{"key":"B114","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1016\/j.jaci.2018.09.036","article-title":"Synergistic convergence of microbiota-specific systemic IgG and secretory IgA","volume":"143","author":"Fadlallah","year":"2019","journal-title":"J Allergy Clin Immunol"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.01914","article-title":"Bacterial but not fungal gut microbiota alterations are associated with common variable immunodeficiency (CVID) phenotype","volume":"10","author":"Fiedorov\u00e1","year":"2019","journal-title":"Front Immunol"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.01654","article-title":"Altered microbiota, impaired quality of life, malabsorption, infection, and inflammation in CVID patients with diarrhoea","volume":"11","author":"van Schewick","year":"2020","journal-title":"Front Immunol"},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.671239","article-title":"Patients with common variable immunodeficiency (CVID) show higher gut bacterial diversity and levels of low-abundance genes than the healthy housemates","volume":"12","author":"Bos\u00e1k","year":"2021","journal-title":"Front Immunol"},{"key":"B118","doi-asserted-by":"publisher","first-page":"1969","DOI":"10.1016\/j.jaci.2019.01.019","article-title":"Selective IgA deficiency in humans is associated with reduced gut microbial diversity","volume":"143","author":"Jorgensen","year":"2019","journal-title":"J Allergy Clin Immunol"},{"key":"B119","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1038\/s41467-017-00900-1","article-title":"The gut microbiome in atherosclerotic cardiovascular disease","volume":"8","author":"Jie","year":"2017","journal-title":"Nat Commun"},{"key":"B120","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s12263-021-00703-6","article-title":"Gut microbiota in patients with obesity and metabolic disorders - a systematic review","volume":"17","author":"Xu","year":"2022","journal-title":"Genes Nutr"},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.115.306807","article-title":"The gut microbiome contributes to a substantial proportion of the variation in blood lipids","volume":"117","author":"Fu","year":"2015","journal-title":"Circ Res"},{"key":"B122","doi-asserted-by":"publisher","DOI":"10.1016\/j.chom.2018.05.012","article-title":"The impact of dietary fiber on gut microbiota in host health and disease","volume":"23","author":"Makki","year":"2018","journal-title":"Cell Host Microbe"},{"key":"B123","doi-asserted-by":"publisher","DOI":"10.1016\/j.tem.2015.09.011","article-title":"Linking microbiota to human diseases: a systems biology perspective","volume":"26","author":"Wu","year":"2015","journal-title":"Trends Endocrinol Metab"},{"key":"B124","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2022.903570","article-title":"The gut microbiota (Microbiome) in cardiovascular disease and its therapeutic regulation","volume":"12","author":"Rahman","year":"2022","journal-title":"Front Cell Infect Microbiol"},{"key":"B125","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1053\/j.gastro.2012.06.031","article-title":"Transfer of intestinal microbiota from lean donors increases insulin sensitivity in individuals with metabolic syndrome","volume":"143","author":"Vrieze","year":"2012","journal-title":"Gastroenterology"},{"key":"B126","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1038\/s41598-018-35367-7","article-title":"Rifaximin alters gut microbiota profile, but does not affect systemic inflammation - a randomized controlled trial in common variable immunodeficiency","volume":"9","author":"Jorgensen","year":"2019","journal-title":"Sci Rep"},{"key":"B127","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2019.08.007","article-title":"Common variable immunodeficiency-associated endotoxemia promotes early commitment to the T follicular lineage","volume":"144","author":"Le Coz","year":"2019","journal-title":"J Allergy Clin Immunol"},{"key":"B128","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20140039","article-title":"Exhaustion of bacteria-specific CD4 T cells and microbial translocation in common variable immunodeficiency disorders","volume":"211","author":"Perreau","year":"2014","journal-title":"J Exp Med"},{"key":"B129","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1194\/jlr.E012138","article-title":"The role of HDL in innate immunity","volume":"52","author":"Feingold","year":"2011","journal-title":"J Lipid Res"},{"key":"B130","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.73.4.2321-2326.2005","article-title":"Lipopolysaccharide is transferred from high-density to low-density lipoproteins by lipopolysaccharide-binding protein and phospholipid transfer protein","volume":"73","author":"Levels","year":"2005","journal-title":"Infect Immun"},{"key":"B131","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.69.5.2821-2828.2001","article-title":"Distribution and kinetics of lipoprotein-bound endotoxin","volume":"69","author":"Levels","year":"2001","journal-title":"Infect Immun"},{"key":"B132","article-title":"The lipemia of sepsis: triglyceride-rich lipoproteins as agents of innate immunity","volume":"6","author":"Harris","year":"2000","journal-title":"J Endotoxin Res"},{"key":"B133","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10081693","article-title":"Lipid and lipoprotein dysregulation in sepsis: clinical and mechanistic insights into chronic critical illness","volume":"10","author":"Barker","year":"2021","journal-title":"J Clin Med"},{"key":"B134","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1038\/nrmicro1068","article-title":"TLR4 and infectious disease diversity","volume":"3","author":"Miller","year":"2005","journal-title":"Nat Rev Microbiol"},{"key":"B135","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.00338","article-title":"Heterogeneity of liver disease in common variable immunodeficiency disorders","volume":"11","author":"Pecoraro","year":"2020","journal-title":"Front Immunol"},{"key":"B136","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.144777","article-title":"Circulating bioactive bacterial DNA is associated with immune activation and complications in common variable immunodeficiency","volume":"6","author":"Ho","year":"2021","journal-title":"JCI Insight"},{"key":"B137","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.01245","article-title":"Low IgA associated with oropharyngeal microbiota changes and lung disease in primary antibody deficiency","volume":"11","author":"Berbers","year":"2020","journal-title":"Front Immunol"},{"key":"B138","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.574500","article-title":"Gut microbiota-dependent trimethylamine n-oxide associates with inflammation in common variable immunodeficiency","volume":"11","author":"Macpherson","year":"2020","journal-title":"Front Immunol"},{"key":"B139","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2014.12.036","article-title":"The TMAO-generating enzyme flavin monooxygenase 3 is a central regulator of cholesterol balance","volume":"10","author":"Warrier","year":"2015","journal-title":"Cell Rep"},{"key":"B140","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1186\/s12944-018-0939-6","article-title":"Trimethylamine-n-oxide (TMAO)-induced atherosclerosis is associated with bile acid metabolism","volume":"17","author":"Ding","year":"2018","journal-title":"Lipids Health Dis"},{"key":"B141","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.120.316242","article-title":"Gut microbiota and cardiovascular disease","volume":"127","author":"Witkowski","year":"2020","journal-title":"Circ Res"},{"key":"B142","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.chom.2022.11.015","article-title":"Two distinct gut microbial pathways contribute to meta-organismal production of phenylacetylglutamine with links to cardiovascular disease","volume":"31","author":"Zhu","year":"2023","journal-title":"Cell Host Microbe"},{"key":"B143","doi-asserted-by":"publisher","first-page":"e010222","DOI":"10.1161\/CIRCHEARTFAILURE.122.010222","article-title":"Phenylacetylglutamine from the gut microbiota: a future therapeutic target in heart failure","volume":"16","author":"Awoyemi","year":"2023","journal-title":"Circ Heart Fail"},{"key":"B144","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/19490976.2021.1897212","article-title":"The role of short-chain fatty acids in the interplay between gut microbiota and diet in cardio-metabolic health","volume":"13","author":"Nogal","year":"2021","journal-title":"Gut Microbes"},{"key":"B145","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1111\/apt.14689","article-title":"Review article: short chain fatty acids as potential therapeutic agents in human gastrointestinal and inflammatory disorders","volume":"48","author":"Gill","year":"2018","journal-title":"Aliment Pharmacol Ther"},{"key":"B146","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2022.09.029","article-title":"Duodenal inflammation in common variable immunodeficiency has altered transcriptional response to viruses","volume":"151","author":"Kaarbo","year":"2023","journal-title":"J Allergy Clin Immunol"},{"key":"B147","doi-asserted-by":"publisher","DOI":"10.1016\/j.mehy.2015.07.002","article-title":"Accelerated atherosclerosis in patients with common variable immunodeficiency: is it overlooked or absent","volume":"85","author":"Ucar","year":"2015","journal-title":"Med Hypotheses"},{"key":"B148","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1186\/s12944-020-01248-0","article-title":"The abnormal lipid profile in obesity and coronary heart disease (CHD) in Pakistani subjects","volume":"19","author":"Shabana","year":"2020","journal-title":"Lipids Health Dis"},{"key":"B149","doi-asserted-by":"publisher","DOI":"10.1093\/eurjpc\/zwab075","article-title":"Primary cardiovascular risk prediction by LDL-cholesterol in Caucasian middle-aged and older adults: a joint analysis of three cohorts","volume":"29","author":"Hilvo","year":"2022","journal-title":"Eur J Prev Cardiol"},{"key":"B150","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(14)70032-4","article-title":"Non-alcoholic fatty liver disease as a cause and a consequence of metabolic syndrome","volume":"2","author":"Yki-J\u00e4rvinen","year":"2014","journal-title":"Lancet Diabetes Endocrinol"},{"key":"B151","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-013-9873-6","article-title":"Nodular regenerative hyperplasia in common variable immunodeficiency","volume":"33","author":"Fuss","year":"2013","journal-title":"J Clin Immunol"},{"key":"B152","doi-asserted-by":"publisher","DOI":"10.3390\/jcdd6020019","article-title":"Cardiovascular risks associated with gender and aging","volume":"6","author":"Rodgers","year":"2019","journal-title":"J Cardiovasc Dev Dis"},{"key":"B153","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2019.07.061","article-title":"From focal lipid storage to systemic inflammation: JACC review topic of the week","volume":"74","author":"Libby","year":"2019","journal-title":"J Am Coll Cardiol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2023.1199727\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,20]],"date-time":"2023-07-20T17:11:11Z","timestamp":1689873071000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2023.1199727\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,20]]},"references-count":153,"alternative-id":["10.3389\/fimmu.2023.1199727"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2023.1199727","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,20]]},"article-number":"1199727"}}